Cytori Therapeutics to Present at the Pacific Growth Equities Life Sciences Growth Conference
Posted on: Wednesday, 31 May 2006, 18:00 CDT
Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) announced today that it will present and provide an audio webcast of its corporate presentation at the Pacific Growth Equities Life Sciences Growth Conference in San Francisco, CA on Tuesday, June 13th at 11:30 a.m. Pacific Daylight Time.
The audio webcast may be accessed under "Events & Webcasts" in the Investor Relations section of the Company's website at http://www.cytoritx.com. The webcast will be available live and by replay one hour after the presentation on the company's website and archived for 14 days.
About Cytori Therapeutics
Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution(TM) System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Source: Business Wire
Related Articles
- Cytori Therapeutics to Webcast 2nd Quarter Results on August 8, 2008
- Cytori Therapeutics to Webcast 2nd Quarter Results on August 14, 2007
- Cytori Therapeutics to Webcast 2007 1st Quarter Results on May 11, 2007
- Cytori Therapeutics to Webcast 2006 4th Quarter and Year End Results on March 30, 2007
- Cytori Therapeutics Authors Review on Opportunity for Adipose Stem & Regenerative Cells in Cosmetic and Reconstructive Surgery
- Cytori Therapeutics to Webcast Second Quarter Financial Results on August 14, 2006
- Cytori Therapeutics Reports Benefit of Adipose Stem and Regenerative Cells in Reconstructive Surgery From Preclinical Study
- Cytori Therapeutics Demonstrates Adipose Stem and Regenerative Cells Reduce Incidence of Arrhythmia After Heart Attacks in Preclinical Study
- Cytori Therapeutics Demonstrates Adipose Stem Cells Improve Cardiac Function in Preclinical Heart Attack Model
- Cytori Therapeutics Presents at Cell-Based Regenerative Medicine Symposium
User Comments (0)

RSS Feeds